Nomogram for predicting severe abdominal pain after initial conventional transarterial chemoembolisation for hepatocellular carcinoma: a retrospective study
Abstract Transarterial chemoembolisation (TACE) is a standard therapy for hepatocellular carcinoma (HCC). However, adverse events, including abdominal pain, are common. This study aimed to investigate and verify the feasibility of a nomogram model to predict severe abdominal pain after first convent...
Main Authors: | Huixia Qin, Xuhua Xiao, Houxiang Ya, Jinhai Li, Fugang Liang, Haiqing Jin, Lianghuan Liao, Yaohua Li, Jiahui Qin, Jue Yu, Jing Gu, Chunmei Zhou, Ming Jin, Ying Miao, Shuqun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-49509-z |
Similar Items
-
Treatment of Large Hepatocellular Carcinoma using Transarterial Chemoembolisation Combined with Sorafenib
by: SD Madhu, et al.
Published: (2021-01-01) -
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01) -
Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Alexander Lawson, et al.
Published: (2023-06-01) -
Cost-effectiveness analysis of adding transarterial chemoembolisation to lenvatinib as first-line treatment for advanced hepatocellular carcinoma in China
by: Wei Li, et al.
Published: (2023-09-01) -
Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region
by: Ana Matilla Peña, et al.
Published: (2015-03-01)